UCHealth coronavirus vaccine trials continue as hospitals prepare for mass vaccination

Advertisement

BEGIN ARTICLE PREVIEW:

UCHealth registered nurse and research coordinator Stacie Kenny administers a shot to the first participant of UCHealth’s COVID-19 vaccine study being conducted in northern Colorado. Participants in the study will receive either a placebo vaccine or a vaccine developed by Oxford University and pharmaceutical company AstraZeneca. Photo courtesy of UCHealth.Photo courtesy of UCHealth.Sponsored content provided by UCHealth.Early results from clinical trials have shown that vaccines may be nearly 95% effective in preventing the transmission of COVID-19.An independent safety and data monitoring board reported this week that early results from the Moderna Phase 3 clinical trials show the company’s vaccine was 94.5% effective.That news followed equally positive preliminary results on Nov. 9 from Pfizer showing that the coronavirus vaccine that Pfizer developed with German drugmaker BioNTech looks to be safe and more than 90% effective in preventing COVID-19 transmission.While Phase 3 trials continue, Moderna and Pfizer are expected to ask the U.S. Food and Drug Administration for emergency approval for their new vaccines later in the coming weeks.Coronavirus vaccine trialsThe news from Moderna and Pfizer bodes well for the beginning the end of the COVID-19 pandemic and for other coronavirus vaccines. Two of them – the Moderna and …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE